Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age

Abstract

Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults. Evidence for their use in children under 12 years of age is limited and based on four studies: three examining azelastine hydrochloride and fluticasone propionate combination (AzeFlu) (including one placebo-controlled efficacy study, one comparative efficacy study, and one safety study) and one examining olopatadine hydrochloride and mometasone furoate combination (OloMom) (a placebo-controlled study). The recommendations from these studies could be conditional for school children aged 6 to 11 years with seasonal (non-perennial) allergic rhinitis, but only when symptoms cannot be controlled with a single drug.

Keywords

allergic rhinitis / combined treatment / corticosteroids / antihistamines / children

References

[1] Rosenfield L, Keith PK, Quirt J, Small P, Ellis AK. Allergic rhinitis. Allergy Asthma Clin Immunol. 2024; 20: 74.

[2] Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic Rhinitis: A Review. JAMA. 2024; 331: 866-77.

[3] Tosca MA, Trincianti C, Naso M, Nosratian V, Ciprandi G. Treatment of Allergic Rhinitis in Clinical Practice. Curr Pediatr Rev. 2024; 20: 271-7.

[4] Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, et al. International consensus statement on allergy and rhinology: Allergic rhinitis - 2023. Int Forum Allergy Rhinol. 2023; 13: 293-859.

[5] Ellis AK, Cook V, Keith PK, Mace SR, Moote W, O’Keefe A, et al. Focused allergic rhinitis practice parameter for Canada. Allergy Asthma Clin Immunol. 2024; 20: 45.

[6] Sousa-Pinto B, Vieira RJ, Brozek J, Cardoso-Fernandes A, Lourenço-Silva N, Ferreira-da-Silva R, et al. Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis. J Allergy Clin Immunol. 2024; 154: 340-54.

[7] Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, et al. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review. Int Arch Allergy Immunol. 2021; 182: 1026-35.

[8] Zhong Z, Xun Y, Shi X, Guan B, Wang M. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis. Eur Arch Otorhinolaryngol. 2022; 279: 2457-64.

[9] Passali D, Passali GC, Damiani V, Ciprandi G. Azelastine/fluticasone and allergic rhinitis in clinical practice. Eur Arch Otorhinolaryngol. 2023; 280: 4713-4.

[10] Chen R, Zheng D, Zhang Y, Sima G. Efficacy and safety of twice-daily olopatadine-mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2022; 279: 1691-9.

[11] Lim L, Lipari M, Kale-Pradhan P. Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis. Ann Pharmacother. 2023; 57: 570-8.

[12] Scadding GK, Smith PK, Blaiss M, Roberts G, Hellings PW, Gevaert P, et al. Allergic Rhinitis in Childhood and the New EUFOREA Algorithm. Front Allergy. 2021; 2: 706589.

[13] Cheng M, Dai Q, Liu Z, Wang Y, Zhou C. New progress in pediatric allergic rhinitis. Front Immunol. 2024; 15: 1452410.

[14] Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, et al. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment. Pediatr Allergy Immunol. 2016; 27: 126-33.

[15] Berger W, Bousquet J, Fox AT, Just J, Muraro A, Nieto A, et al. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children. Allergy. 2016; 71: 1219-22.

[16] Berger W, Sher E, Gawchik S, Fineman S. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial. Allergy Asthma Proc. 2018; 39: 110-6.

[17] Prenner BM, Amar NJ, Hampel FC Jr, Caracta CF, Wu W. Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2022; 129: 618-26.e2.

[18] Li Y, Xiong J, Zhang Z, Liao K, Zho X, Li J, et al. Efficacy and safety of various corticosteroids in the treatment of children with allergic rhinitis: A systematic review and network meta-analysis. J Evid Based Med. 2024; 17: 626-42.

[19] Lipworth BJ, Stewart K, Kuo CR, Chan R. Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis? J Allergy Clin Immunol Pract. 2024; 12: 1434-5.

[20] Gil-Mata S, Vieira RJ, Borowiack E, Sadowska E, Bognanni A, Cardoso-Fernandes A, et al. ARIA 2024 Guideline Panel. Intranasal Treatments for Allergic Rhinitis in Preschool- and School-Age Children: Network Meta-Analysis. J Allergy Clin Immunol Pract. 2025; 13: 2826-37.